NCT03962543 2025-08-07
ReNeu
SpringWorks Therapeutics, Inc.
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT05580770 2025-02-17
Mirdametinib + BGB-3245 in Advanced Solid Tumors
SpringWorks Therapeutics, Inc.
Phase 1/2 Terminated
NCT05028166 2024-03-15
Individual Patient Compassionate Use of Mirdametinib
SpringWorks Therapeutics, Inc.
Available
NCT00174369 2009-03-17
MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
Pfizer
Phase 2 Terminated